Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It also develoes APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Aptevo Therapeutics Inc..
Aptevo Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Aptevo Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Aptevo Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Aptevo Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Aptevo Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Aptevo Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Aptevo Therapeutics Inc.- Key Facts
2.2 Aptevo Therapeutics Inc.- Geographic Locations
2.3 Aptevo Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Aptevo Therapeutics Inc.- Business Divisions
2.5 Aptevo Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Aptevo Therapeutics Inc. Strategic Analysis Review
3.1 Aptevo Therapeutics Inc.- Key Strategies
3.2 Aptevo Therapeutics Inc.- Company Outlook Statement
3.3 Aptevo Therapeutics Inc.- SWOT Analysis
3.3.1 Aptevo Therapeutics Inc.- Key Strengths
3.3.2 Aptevo Therapeutics Inc.- Key Weaknesses
3.3.3 Aptevo Therapeutics Inc.- Potential Opportunities
3.3.4 Aptevo Therapeutics Inc.- Potential Threats
3.4 Aptevo Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Aptevo Therapeutics Inc.- Business Overview
4.2 Aptevo Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Aptevo Therapeutics Inc.- Key Products
5.2 Aptevo Therapeutics Inc.- Key Service Areas
5.3 Aptevo Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Aptevo Therapeutics Inc.- Company History
6.2 Aptevo Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Aptevo Therapeutics Inc.- Income Statements
7.2 Aptevo Therapeutics Inc.- Balance Sheet
7.3 Aptevo Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Aptevo Therapeutics Inc.- Direct Competitors
8.2 Aptevo Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Aptevo Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Aptevo Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!